Publications by authors named "Jason H Brett"

Claim this Profile
L
Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trials.
John B Buse, Alan Garber, Julio Rosenstock, Wolfgang E Schmidt, Jason H Brett

J Clin Endocrinol Metab· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett

Lancet· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis